Bostwick Bret L, McLean Scott, Posey Jennifer E, Streff Haley E, Gripp Karen W, Blesson Alyssa, Powell-Hamilton Nina, Tusi Jessica, Stevenson David A, Farrelly Ellyn, Hudgins Louanne, Yang Yaping, Xia Fan, Wang Xia, Liu Pengfei, Walkiewicz Magdalena, McGuire Marianne, Grange Dorothy K, Andrews Marisa V, Hummel Marybeth, Madan-Khetarpal Suneeta, Infante Elena, Coban-Akdemir Zeynep, Miszalski-Jamka Karol, Jefferies John L, Rosenfeld Jill A, Emrick Lisa, Nugent Kimberly M, Lupski James R, Belmont John W, Lee Brendan, Lalani Seema R
Department of Molecular and Human Genetics, Baylor College of Medicine, 6701 Fannin St, Suite 1560, Houston, TX, 77030, USA.
Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, 78207, USA.
Genome Med. 2017 Aug 14;9(1):73. doi: 10.1186/s13073-017-0463-8.
De novo missense variants in CDK13 have been described as the cause of syndromic congenital heart defects in seven individuals ascertained from a large congenital cardiovascular malformations cohort. We aimed to further define the phenotypic and molecular spectrum of this newly described disorder.
To minimise ascertainment bias, we recruited nine additional individuals with CDK13 pathogenic variants from clinical and research exome laboratory sequencing cohorts. Each individual underwent dysmorphology exam and comprehensive medical history review.
We demonstrate greater than expected phenotypic heterogeneity, including 33% (3/9) of individuals without structural heart disease on echocardiogram. There was a high penetrance for a unique constellation of facial dysmorphism and global developmental delay, as well as less frequently seen renal and sacral anomalies. Two individuals had novel CDK13 variants (p.Asn842Asp, p.Lys734Glu), while the remaining seven unrelated individuals had a recurrent, previously published p.Asn842Ser variant. Summary of all variants published to date demonstrates apparent restriction of pathogenic variants to the protein kinase domain with clustering in the ATP and magnesium binding sites.
Here we provide detailed phenotypic and molecular characterisation of individuals with pathogenic variants in CDK13 and propose management guidelines based upon the estimated prevalence of anomalies identified.
在一个大型先天性心血管畸形队列中确诊的7例个体中,CDK13的新生错义变异被描述为综合征性先天性心脏缺陷的病因。我们旨在进一步明确这种新描述疾病的表型和分子谱。
为尽量减少选择偏倚,我们从临床和研究外显子组实验室测序队列中招募了另外9例携带CDK13致病变异的个体。每位个体均接受了畸形学检查和全面的病史回顾。
我们发现表型异质性高于预期,包括33%(3/9)的个体超声心动图检查无结构性心脏病。面部畸形和全面发育迟缓这一独特组合具有较高的外显率,以及较少见的肾脏和骶骨异常。2例个体有新的CDK13变异(p.Asn842Asp、p.Lys734Glu),而其余7例无亲缘关系的个体有一个之前已发表的复发性p.Asn842Ser变异。对迄今已发表的所有变异的总结表明,致病变异明显局限于蛋白激酶结构域,且聚集在ATP和镁结合位点。
在此,我们提供了携带CDK13致病变异个体的详细表型和分子特征,并根据所确定异常的估计患病率提出了管理指南。